Results 1 to 10 of about 5,690,892 (209)

Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells [PDF]

open access: yesCurrent Issues in Molecular Biology, 2022
Imatinib has been the first and most successful tyrosine kinase inhibitor (TKI) for chronic myeloid leukemia (CML), but many patients develop resistance to it after a satisfactory response. Glutathione (GSH) metabolism is thought to be one of the factors
Priyanka Singh   +3 more
doaj   +2 more sources

Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells

open access: yesMolecules, 2013
In this article, reversal activities of Euphorbia factor L1 (EFL1) against ABCB1-mediated multidrug resistance (MDR) and apoptosis sensitization in K562/ADR cells are reported.
Zhong-Zhen Zhao   +7 more
doaj   +2 more sources

PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells [PDF]

open access: yesBMC Cancer, 2007
Background The objective of this study was to gain insight into the molecular mechanism of induced cell death (apoptosis) by PYRROLO [1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) series compounds, using human (K562) cells as a model.
Morgante Emanuela   +13 more
doaj   +2 more sources

Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells

open access: yesMolecules, 2014
P-glycoprotein (P-gp) is a major factor in multidrug resistance (MDR) which is a serious obstacle in chemotherapy. P-gp has also been implicated in causing apoptosis of tumor cells, which was shown to be another important mechanism of MDR recently.
Yaqiong Zu   +4 more
doaj   +3 more sources

Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. [PDF]

open access: yesCell Mol Life Sci, 2023
Karagiannis TC   +11 more
europepmc   +2 more sources

CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia

open access: yesCell Death Discovery, 2021
Internal tandem duplication (ITD) of FMS-like tyrosine kinase 3 (FLT3) confers poor prognosis and is found in approximately 25% of cases of acute myeloid leukemia (AML).
Sivasundaram Karnan   +20 more
doaj   +1 more source

X-ray-irradiated K562 feeder cells for expansion of functional CAR-T cells

open access: yesBiochemistry and Biophysics Reports, 2023
Immunotherapy, particularly CAR-T therapy has recently emerged as an innovator for cancer treatment. Gamma-irradiated K562 cells is a common and effective method to stimulated CAR-T cells prior to treatment.
Khac Cuong Bui   +12 more
doaj   +1 more source

Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state

open access: yesToxicology Reports, 2022
The objective was to investigate the effect of 4-hydroxybenzoic acid (4-HBA) and 4-hydroxy-3-methoxybenzoic acid (Vanillic acid, VA) on p-glycoprotein (P-gp) activity in multidrug-resistant K562/Dox cancer cells.
Ohnmar Myint   +5 more
doaj   +1 more source

Two lymphoid cell lines potently silence unintegrated HIV-1 DNAs

open access: yesRetrovirology, 2022
Mammalian cells mount a variety of defense mechanisms against invading viruses to prevent or reduce infection. One such defense is the transcriptional silencing of incoming viral DNA, including the silencing of unintegrated retroviral DNA in most cells ...
Franziska K. Geis   +2 more
doaj   +1 more source

hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562. [PDF]

open access: yesPLoS ONE, 2013
The hERG potassium channel can modulate the proliferation of the chronic myelogenous leukemic K562 cells, and its role in the erythroid differentiation of K562 cells still remains unclear.The hERG potassium channel blockage by a new 36-residue scorpion ...
Jian Ma   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy